<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
ViroLogic, Inc.
______________________________________________________
(Exact name of registrant as specified in its charter)
Delaware 94-3234479
_______________________________________ ____________________________________
(State of Incorporation or Organization) (I.R.S. Employer Identification no.)
270 East Grand Avenue, South San Francisco, CA 94080
______________________________________________ __________
(Address of principal executive offices) (zip code)
If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective upon filing pursuant to
General Instruction A.(c), check the following box. [ ]
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), check the following box. [x]
Securities Act registration statement file number to 333-30896
which this form relates: _______________
(If applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class to Name of Each Exchange on Which
be so Registered Each Class is to be Registered
______________________ ______________________________
None
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, par value $0.001 per share
________________________________________
(Title of class)
<PAGE> 2
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
Incorporated by reference to the section entitled "Description of Capital Stock"
beginning on page 49 of the preliminary prospectus contained in Registrant's
Registration Statement on Form S-1 filed with the Commission on February 22,
2000 (No. 333-30896), as amended.
ITEM 2. EXHIBITS.
Exhibit
Number Description
1. Specimen Common Stock Certificate.(1)
2. Registrant's Amended and Restated Certificate of Incorporation.(2)
3. Registrant's Amended and Restated Certificate of Incorporation.(3)
4. Registrant's Bylaws.(4)
5. Registrant's Bylaws.(5)
___________________
(1) Filed with the Securities and Exchange Commission as exhibit 4.2
to Registrant's Form S-1 Registration Statement, No. 333-30896, as
amended, and incorporated herein by reference.
(2) Filed with the Securities and Exchange Commission as exhibit 3.3
to Registrant's Form S-1 Registration Statement, No. 333-30896, as
amended, and incorporated herein by reference, as currently in
effect.
(3) Filed with the Securities and Exchange Commission as exhibit 3.5
to Registrant's Form S-1 Registration Statement, No. 333-30896, as
amended, and incorporated herein by reference, to be filed and
become effective after the closing of the offering.
(4) Filed with the Securities and Exchange Commission as exhibit 3.4
to Registrant's Form S-1 Registration Statement, No. 333-30896, as
amended, and incorporated herein by reference, as currently in
effect.
(5) Filed with the Securities and Exchange Commission as exhibit 3.5
to Registrant's Form S-1 Registration Statement, No. 333-30896, as
amended, and incorporated herein by reference, to become effective
prior to the closing of this offering.
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, as amended, the Registrant has duly caused this registration statement
to be signed on its behalf by the undersigned, thereto duly authorized.
VIROLOGIC, INC.
(REGISTRANT)
Date: April 14, 2000 By: /S/ ROBIN M. TOFT
-----------------
Robin M. Toft
VICE PRESIDENT,
SALES AND MARKETING
